Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no adverse effects ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Cell-based therapies that replenish dopamine neurons in the brain are showing early promise as a potentially more effective treatment ... from human induced pluripotent stem (iPS) cells, with ...

Patients suffering from Parkinson's disease may soon benefit from a powerful treatment option: stem-cell transplants ... A second study by researchers in Kyoto, Japan, used induced pluripotent stem ...

Apr. 25, 2025 — Chimpanzee naive pluripotent stem cells (PSCs) can now be grown in cellular cultures, reveals a recent study. They successfully created chimpanzee early embryo models ...

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with fewer side effects.

Cell therapy, specifically replenishing dopamine ... received transplantation of dopaminergic progenitors derived from human induced pluripotent stem cells into both sides of the brain.

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning ...